Kidney transplantation in the cyclosporine era.
Seventy-seven patients underwent transplantation, using a cyclosporine-prednisone immunosuppression protocol. No recipients died, and graft survival at one year was 100% for living related donor (LRD) recipients and 84% for cadaver donor (CD) recipients. Nineteen percent of locally harvested, flush-cooled kidney recipients required dialysis, whereas imported kidneys had a 66% dialysis rate. Infectious complications occurred in 17% of patients. Mean hospitalization was 12.8 days for LRD recipients and 13.6 days for CD recipients. Twenty-eight patients required 37 readmissions, mostly for treatment of rejection and infections. Total two-year cost for LRD transplants was +21,400; for CD transplants, +23,900.
Halasz
N A
NA
Gamboa
E A
EA
Ward
D M
DM
Steiner
R W
RW
Bronsther
O L
OL
D003524:Cyclosporins / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006084:Graft Rejection / Q000187:drug effects*; D006801:Humans; D016030:Kidney Transplantation; D008297:Male; D011183:Postoperative Complications / Q000209:etiology / Q000628:therapy; D011241:Prednisone / Q000627:therapeutic use*; D006435:Renal Dialysis; D012086:Reoperation; D009927:Tissue and Organ Procurement
D003524:Cyclosporins; D011241:Prednisone